TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: Expected value and dispersion of Structured Light Phlethysmography
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Responses to VVAQ
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Security of uterus transplantation
Endpoint domain: Adverse events/effects
Primary endpoint: Area Under the Receiver Operator Curve (AUROC)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in IBS symptom severity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Incidences of Protocol-defined DLT
Endpoint domain: Adverse events/effects
Primary endpoint: Proportion of patients showing a PSA decline of ≥50%
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Y Balance Test/ Dynamic Balance Evaluation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Flamingo Balance Test/ Static Balance Evaluation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Unaided Visual Acuity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of treatment-emergent side effects measured with the ASEC
Endpoint domain: Adverse events/effects
Primary endpoint: Response to treatment defined by CGI-I score below 3
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Two-Year Survival
Endpoint domain: Mortality/survival
Primary endpoint: Employment Hours Worked
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Worker Well-being
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Financial Burden of Employed Males with Cancer
Endpoint domain: Resource use
Endpoint subdomain: Societal/carer burden
Primary endpoint: Number of Participants With Serious Events Associated With all-Cause Hospitalizations
Endpoint domain: Adverse events/effects
Primary endpoint: occurrence of serious device-related adverse events
Endpoint domain: Adverse events/effects
Primary endpoint: successful completion of the Dexter-assisted procedure
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Nutrition status - scored Patient-Generated Subjective Global Assessment (PG-SGA)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Changes in Freezing of Gait
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Colonic Adenomas Detection Rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: complete closure
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rate of participants with virologic suppression
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Change of CD4 count
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Rate of immune reconstitution in late presenters
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: 3D dynamic parameters
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Frankl Behavioral Rating Scale (FBRS)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Changes in fasting blood glucose level
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Changes in Blood Pressure Level
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Proportion of participants who discontinued OCS without loss of asthma control
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of participants who reduced daily prescribed maintenance OCS dose to ≤ 5 mg/day without loss of asthma control
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Participation in quality-assured exercise therapy
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Change of BEWE (Basic Erosive Wear Examination)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Schiff Air Index - Dental sensitivity test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Plaque Index (PI% - O' Leary Index)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Months of PrEP persistence
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Access to sickle cell disease screening and care
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Access to evidence-based care for sickle cell disease
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Impact of a coordinated screening and treatment program
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Ejection fraction using M mode echocardiography
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Fraction shortening by M mode echocardiography
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Assessment of pulmonary hypertension
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Adherence as assessed by self-reported food consumption scores
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Satisfaction as assessed by focus groups and the CSQ-8
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Vitamin B12 levels in the blood
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Neutrophil analysis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: change in sleep-related quality of life
Endpoint domain: Life impact
Endpoint subdomain: Sleep
Primary endpoint: Lower Extremity Skin Temperature
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Stress ulcer prophylaxis appropriate rate
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Minimal Clinically Important Improvement (MCII)
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Total consumption of IV glyceryl trinitrate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Incidence of diaphragmatic excursion reduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Regression of cervical lesions
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Tilt and decentration of intraocular lens
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Threshold from the Virtual Eggs Test (VET)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mobility of internal rotation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Tendon healing assessment
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Mean Fidelity Score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Effects of tDCS on computerised gamified short-term memory task performance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in knowledge of precision medicine for cancer care
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Freedom from Device Related Major Adverse Events
Endpoint domain: Adverse events/effects
Primary endpoint: Reduction of Mitral Regurgitation Grade to ≤ 1+
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Number of Falls and Fall-Related Injuries
Endpoint domain: Adverse events/effects
Primary endpoint: Knowledge Test Score
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Incidence and profile of dose-limiting toxicity (DLT)
Endpoint domain: Adverse events/effects
Primary endpoint: Maximum tolerated dose and/or recommended dose for further clinical trial
Endpoint domain: Adverse events/effects
Primary endpoint: Sensibility of RIUS in metastasis detection
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Predictive value of clinical examination findings and albuminuria for AKI
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: SUV value of radioactive material uptake
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Thickness of the Perfused boundary region (PBR)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of eligible participants enrolled
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Change in myokine and exerkine concentration in the blood plasma
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Acceptability of treatment
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Increase in CD3+ tumor infiltrating T cells
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Treatment failure on escitalopram
Endpoint domain: Adverse events/effects
Primary endpoint: F wave
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Mean serum ctDNA concentration
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Retinal arteriolar and venular dilation and diameters
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: Change from baseline in Psoriasis Area and Severity Index (PASI)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: mean number episodes of abdominal pain
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Irritable bowel Syndrome-Severity score
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Change in child discomfort
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Change in dental anxiety
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Health-related life quality
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Number of pills taken
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Standard Usability Score
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Change in neck disability
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Change in frequency of headache
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage of participants with treatment response after 4 weeks
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage of participants with treatment response after 8 weeks
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in KPPS
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in MKPPS
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in pain intensity scores (VAS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rate of Handwashing with soap at stool and food related events
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of constructed homemade handwashing stations
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: change in estimated annual income
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Efficacy of ozone-based eye drops in treating microbial keratitis
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of participants requiring rescue opioid administration
Endpoint domain: Adverse events/effects
Primary endpoint: Excess tidal volume
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Bone flap alignment score
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: First episode of RSV-LRTD after vaccination
Endpoint domain: Adverse events/effects
Primary endpoint: Bladder Volume at first desire to void
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Detrusor pressure At Qmax
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Accuracy
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Generalisation to connected speech
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Number of Participants with Any Serious AEs (SAEs), Medically Attended AEs (MAAEs), AEs Leading to Withdrawal From Study/Discontinuation of Study Vaccine, and AEs of Special Interest (AESIs)
Endpoint domain: Adverse events/effects
Primary endpoint: Unified Huntington's Disease Rating Scale (UHDRS) Total Motor Score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Unified Huntington's Disease Rating Scale (UHDRS) Total Functional Capacity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Unified Huntington's Disease Rating Scale (UHDRS) Diagnostic Confidence Level
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Patient and family-perceived efficacy
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Utility of a pilot psychoeducation program
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Limit of Agreement (LOA) between P200TE and predicate device measurements of full retinal thickness
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Limit of Agreement (LOA) between P200TE and predicate device measurements of retinal nerve fiber layer thickness
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Limit of Agreement (LOA) between P200TE and predicate device measurements of ganglion cell complex thickness
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Limit of Agreement (LOA) between P200TE and predicate device measurements of optic disc
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Precision between P200TE and predicate device measurements of full retinal thickness
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Assessment of osteomyoarticular symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Assessment of perineal pain intensity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of patients who are progression free at multiple intervals
Endpoint domain: Mortality/survival
Primary endpoint: Proportion of patients alive 1 and 2 years post palbociclib combination initiation
Endpoint domain: Mortality/survival
Primary endpoint: Increase in penile width and girth
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: 30-day biochemically confirmed cigarette smoking cessation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Efficacy of Dinutuximab Beta
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: BAB permeability
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Support practices perception score
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Biochemically-Verified smoking cessation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Accelerometer-verified reduction in sedentary time
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Main cardiovascular events
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Physical Activity Self-Efficacy Scale (PASS)
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Attitude toward Physical Activity Scale (APAS)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Evaluation consistency
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Serum levels of Magnesium
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Serum levels of Zinc
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Shuttle Run test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: 12 min run test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mcdonald Soccer skill test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reproductive and sexual function
Endpoint domain: Physiological/clinical
Endpoint subdomain: Reproductive system and breast outcomes
Primary endpoint: Change in the tumor/brain extracellular guanidinoacetate ratio
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Initial neonatal glucose post delivery
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Regression of primary uveal melanoma
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Change from Self-report Pain Intensity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change from Central Sensitization symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: EMG changes
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Change from Baseline Fatigue at five weeks
Endpoint domain: Life impact
Endpoint subdomain: Fatigue
Primary endpoint: Change from Baseline Energy Level at five weeks
Endpoint domain: Life impact
Endpoint subdomain: Fatigue
Primary endpoint: Change from Baseline Well-being at five weeks
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Area Under the Concentration-Time Curve from Time 0 to Infinity (AUC0-Inf) of Islatravir Metabolite
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Maximum Concentration (Cmax) of Islatravir Metabolite
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Apparent Terminal Half-life (t1/2) of Islatravir Metabolite
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Collection of medical and sociological data
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Clinical Gait Assessment Scale
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Urinary Excretion of LY3372689 Radioactivity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Fecal Excretion of LY3372689 Radioactivity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Changes in GVFQ-40 scores
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Changes in NEI VFQ-25 scores
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Changes in LVQOL scores
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Time-Weighted Average (TWA) for MAP below 65 mmHg
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Time-Weighted Average (TWA) for MAP above 100 mmHg
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Change in VISIA Imaging System Analysis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Duration of Clinical Efficacy
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of arterial desaturation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Change in blood glucose during exercise
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Brain connectome
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Fractional muscle protein synthesis rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Recurrence of Dupuytren's Contracture
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage of treatment success based on investigator's global assessment (IGA)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Percentage change in total skin lesion counts compared to baseline
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Percentage change in the count of inflammatory skin lesions compared to baseline
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: changes in skin texture and homogeneity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Composite of cardiac mortality, heart transplant, or LVAD implantation
Endpoint domain: Mortality/survival
Primary endpoint: cellular senescence (SA-B-gal activity)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: damaged telomeres (FISH/IF)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Absolute Bioavailability of Dexamethasone
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes